Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
Katten‘s ’patent litigation practice specializes in Hatch-Waxman cases for leading generic drug companies. Recently, the team worked on a high-profile case representing Sun Pharmaceutical Industries in defending their generic version of Ozempic. Deepro Mukerjee, based in New York, is ‘a stand-out patent litigator’ who oversees trial and appellate proceedings. Mukerjee also has experience managing IPR proceedings before the PTAB. Mukerjee chairs the department alongside New-York-based Lance Soderstrom, a seasoned litigator with expertise in pharmaceutical compounds and medical devices, and Chicago-based Brian Sodikoff, who also focuses on Hatch-Waxman patent litigation, drawing on his background in competition law.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Extremely competent group of attorneys, led by Mr Deepro Mukerjee. They use common sense, value-driven billing with an eye towards results.’
‘Mr. Deepro Mukerjee is a stand-out patent litigator, immensely talented and results-driven, and leader of the patent litigation team at Katten. He has a keen understanding of his client's business needs and focuses his advice on a legal and business perspective. ’
Clients clés
- Apotex Corp. / Apotex Inc.
- Avocados Plus
Points forts
- Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Ozempic, a popular diabetes drug that people also take for weight loss.
- Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Wegovy, an injectable weight-loss medication for adults with obesity or excess weight with weight-related conditions.